Workflow
Solaris Energy Infrastructure, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your Rights – SEI
GlobeNewswire News Room· 2025-05-16 17:18
Core Viewpoint - A class action securities lawsuit has been filed against Solaris Energy Infrastructure, Inc. due to alleged securities fraud affecting investors between July 9, 2024, and March 17, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who were adversely affected by alleged securities fraud during the specified period [2]. - The complaint alleges that the defendants made false statements and concealed critical information regarding Mobile Energy Rentals LLC (MER), including its lack of corporate history in mobile turbine leasing and a non-diversified earnings stream [3]. - It is claimed that MER's co-owner has a criminal background associated with turbine-related fraud, leading to an overstatement of Solaris's commercial prospects from the acquisition [3]. - The lawsuit also alleges that Solaris inflated profitability metrics by failing to properly depreciate its turbines, resulting in materially misleading statements about the company's business and operations [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until May 27, 2025, to request to be appointed as lead plaintiff, although participation does not require serving in this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [4]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [5]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [5].
Shareholders that lost money on Open Lending Corporation (LPRO) should contact Levi & Korsinsky about pending Class Action - LPRO
GlobeNewswire News Room· 2025-05-16 17:18
Core Viewpoint - A class action securities lawsuit has been filed against Open Lending Corporation, alleging securities fraud that affected investors between February 24, 2022, and March 31, 2025 [1]. Group 1: Allegations of Fraud - The lawsuit claims that the defendants made false statements regarding the Company's risk-based pricing models and misrepresented profit share revenue [2]. - It is alleged that the Company failed to disclose that its 2021 and 2022 vintage loans had significantly decreased in value compared to their outstanding loan balances [2]. - The complaint also states that the defendants misrepresented the underperformance of the Company's 2023 and 2024 vintage loans, leading to materially misleading statements about the Company's business and prospects [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Open Lending Corporation during the specified timeframe have until June 30, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require individuals to serve as lead plaintiffs, and there are no out-of-pocket costs for class members [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].
Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 – VTRS
GlobeNewswire News Room· 2025-05-16 17:17
Core Viewpoint - A class action securities lawsuit has been filed against Viatris Inc. due to alleged securities fraud impacting investors between August 8, 2024, and February 26, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Viatris misrepresented the implications of a warning letter from the FDA regarding its Indore, India facility, downplaying its significance as a "minor headwind" [2] - Following the announcement of disappointing financial results for Q4 and fiscal year 2024 on February 27, 2025, Viatris' stock price dropped from $11.24 to $9.53, a decline of approximately 15.21% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]
July 1, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CIVI
GlobeNewswire News Room· 2025-05-16 17:16
Core Viewpoint - Civitas Resources, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between February 27, 2024, and February 24, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Civitas was likely to significantly reduce its oil production in 2025 due to declines following a production peak at the DJ Basin in Q4 2024 and a low TIL count at the end of 2024 [2] - Increasing oil production would necessitate acquiring additional acreage and development locations, leading to significant debt and potential asset sales to offset acquisition costs [2] - The financial condition of Civitas would require disruptive cost reduction measures, including a significant workforce reduction [2] - Consequently, the business and financial prospects, as well as operational capabilities of Civitas, were overstated, making public statements materially false and misleading [2] Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until July 1, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky has secured hundreds of millions of dollars for shareholders over the past 20 years and has a strong track record in high-stakes cases [4] - The firm specializes in complex securities litigation and has a team of over 70 employees dedicated to serving clients [4] - For seven consecutive years, Levi & Korsinsky has been ranked in the Top 50 Report by ISS Securities Class Action Services as one of the leading securities litigation firms in the United States [4]
Should You Buy, Sell or Hold INOD Stock After Q1 Earnings Beat?
ZACKS· 2025-05-16 17:15
Core Insights - Innodata Inc. (INOD) reported a strong first-quarter 2025 performance with revenues increasing by 120% year-over-year to $58.3 million and an EPS of 22 cents, surpassing expectations [1][4] - The company reaffirmed its full-year revenue growth guidance of over 40% and is making significant strides in expanding AI-driven services across various sectors [1][8] Financial Performance - Adjusted EBITDA rose by 236% to $12.7 million, representing 22% of revenues, indicating scalable operating leverage [4] - The adjusted gross margin was 43%, exceeding the long-term target of 40%, showcasing profitable execution as the company scales its operations [4] Client Relationships and Growth Opportunities - Innodata is expanding its relationships with major clients, including a second master statement of work with its largest client, tapping into a significantly larger budget [5] - The company secured approximately $8 million in new engagements from four other Big Tech customers and is in discussions with five additional clients, potentially leading to over $30 million in near-term awards [5][6] Financial Position - With $56.6 million in cash and no debt drawn from its $30 million credit facility, Innodata is well-positioned to reinvest in AI platform development and strategic hiring [7] - The company plans to reinvest operational cash in 2025 towards technology and strategic hires to support AI growth while still expecting to grow adjusted EBITDA compared to 2024 [8] Market Position and Valuation - Innodata's current valuation appears stretched, with a one-year forward price-to-sales ratio of 4.31, significantly above the industry average of 1.76, indicating that investors may have already priced in much of the anticipated growth [13] - The company is positioned as a foundational infrastructure partner for major tech leaders, which are expected to invest billions in AI infrastructure throughout 2025, creating substantial opportunities for Innodata [16] Risks and Considerations - Despite strong performance, Innodata remains heavily dependent on a single large customer, which generated a $135 million annualized run rate in 2024, posing operational risks if contract renewals slow [9] - Management's plan to invest in new programs may impact near-term margins, increasing risk if new projects are delayed or underperform [10]
Lost Money on Everus Construction Group, Inc. (ECG)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire News Room· 2025-05-16 17:15
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Everus Construction Group, Inc. ("Everus Construction " or the "Company") (NYSE: ECG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Everus Construction investors who were adversely affected by alleged securities fraud between October 31, 2024 and February 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk. ...
Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
GlobeNewswire News Room· 2025-05-16 17:14
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. Follow the link below to get more information and be contacted by a ...
June 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAR
GlobeNewswire News Room· 2025-05-16 17:13
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avis Budget investors who were adversely affected by alleged securities fraud between February 16, 2024 and February 10, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/avis-budge ...
Security Bancorp, Inc. Announces Annual Cash Dividend
GlobeNewswire· 2025-05-16 17:13
Group 1 - Security Bancorp, Inc. declared an annual cash dividend of $1.00 per share on its outstanding common stock [1] - The cash dividend will be payable on July 1, 2025, to shareholders of record as of June 2, 2025 [1] Group 2 - As of March 31, 2025, Security Bancorp, Inc. had total assets of $391.8 million and stockholders' equity of $37.1 million [2] - Security Bancorp, Inc. is the holding company for Security Federal Savings Bank, a Tennessee state-chartered financial institution headquartered in McMinnville, Tennessee [2]
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 – SANA
GlobeNewswire News Room· 2025-05-16 17:12
Core Viewpoint - A class action securities lawsuit has been filed against Sana Biotechnology, Inc. due to alleged securities fraud affecting investors between March 17, 2023, and November 4, 2024 [1][2]. Group 1: Allegations and Financial Concerns - The lawsuit claims that Sana was at significant risk of having insufficient funds to maintain its operations and advance its product candidates [2]. - It is alleged that the product candidates SC291 in oncology, SC379, and SG299 were less promising than previously communicated to investors [2]. - To preserve cash and focus on more promising candidates, Sana was likely to decrease funding for or discontinue SC291, SC379, and SG299, as well as significantly reduce its workforce [2]. - The defendants are accused of overstating Sana's financial capacity to maintain operations and advance existing product candidates, leading to materially false and misleading public statements [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant timeframe have until May 20, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].